Diabetes

Elevated HbA1c usually leads to prompt Tx start, intensification

(HealthDay)—Most patients are newly initiated on antidiabetic therapy or have antidiabetic therapy intensified within six months of hemoglobin A1c (HbA1c) elevation, according to a study published online May 24 in Diabetes ...

Medical research

Team discovers how drug prevents aging and cancer progression

University of Montreal researchers have discovered a novel molecular mechanism that can potentially slows the aging process and may prevent the progression of some cancers. In the March 23 online edition of the prestigious ...

Medications

Added benefit of dapagliflozin is not proven

Dapagliflozin (trade name: Forxiga) has been approved in Germany since November 2012 for the treatment of type 2 diabetes mellitus. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal ...

Diseases, Conditions, Syndromes

DPP-4 inhibitors not tied to pneumonia hospitalizations

(HealthDay)—The use of dipeptidyl peptidase-4 (DPP-4) inhibitors is not associated with an increased risk of hospitalization for community-acquired pneumonia, according to a study published in the April issue of Diabetes, ...

Oncology & Cancer

Exploring therapeutic interventions for pancreatic cancer

Pancreatic cancer is a devastating disease due to its often late diagnosis and its unresponsiveness to current therapies. It is estimated that 57,600 new cases were diagnosed in 2020 in the U.S., with a dismal 10%five-year ...